These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 17762609)
1. Type II collagen markers in osteoarthritis: what do they indicate? Henrotin Y; Addison S; Kraus V; Deberg M Curr Opin Rheumatol; 2007 Sep; 19(5):444-50. PubMed ID: 17762609 [TBL] [Abstract][Full Text] [Related]
3. [Biochemical markers of bone turnover. New aspect. Biomarkers of cartilage metabolism]. Okano T; Koike T Clin Calcium; 2009 Aug; 19(8):1149-58. PubMed ID: 19638699 [TBL] [Abstract][Full Text] [Related]
4. Clinical validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide: A biomarker of matrix metalloproteinase activity and osteoarthritis in human urine. Li WW; Nemirovskiy O; Fountain S; Rodney Mathews W; Szekely-Klepser G Anal Biochem; 2007 Oct; 369(1):41-53. PubMed ID: 17570334 [TBL] [Abstract][Full Text] [Related]
5. Biomarkers of cartilage turnover. Part 1: Markers of collagen degradation and synthesis. Garvican ER; Vaughan-Thomas A; Innes JF; Clegg PD Vet J; 2010 Jul; 185(1):36-42. PubMed ID: 20488735 [TBL] [Abstract][Full Text] [Related]
6. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy. Jansen NW; Roosendaal G; Lundin B; Heijnen L; Mauser-Bunschoten E; Bijlsma JW; Theobald M; Lafeber FP Arthritis Rheum; 2009 Jan; 60(1):290-8. PubMed ID: 19116938 [TBL] [Abstract][Full Text] [Related]
7. Design and validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide in human urine: application as a biomarker of osteoarthritis. Nemirovskiy O; Li WW; Szekely-Klepser G Methods Mol Biol; 2010; 641():253-70. PubMed ID: 20407952 [TBL] [Abstract][Full Text] [Related]
8. Biological markers in osteoarthritis. Rousseau JCh; Garnero P Bone; 2012 Aug; 51(2):265-77. PubMed ID: 22538364 [TBL] [Abstract][Full Text] [Related]
10. [Role of cleavage of type II collagen by collagenase in osteoarthritis and its progression]. Kojima T Clin Calcium; 2004 Jul; 14(7):90-3. PubMed ID: 15577083 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and mechanism of action of KHBJ-9B, a new herbal medicine, and its major compound triterpenoids in human cartilage culture and in a rabbit model of collagenase-induced osteoarthritis. Huh JE; Baek YH; Ryu SR; Lee JD; Choi DY; Park DS Int Immunopharmacol; 2009 Feb; 9(2):230-40. PubMed ID: 19100343 [TBL] [Abstract][Full Text] [Related]
12. [Absolute risk for fracture and WHO guideline. Biological markers for osteoarthritis (OA)]. Date H; Yamada H; Kanaji A; Tajima K; Hayakawa K; Maehara K; Miyazaki K; Masuda H; Clin Calcium; 2007 Jul; 17(7):1071-9. PubMed ID: 17607075 [TBL] [Abstract][Full Text] [Related]
13. Discovery and development of a type II collagen neoepitope (TIINE) biomarker for matrix metalloproteinase activity: from in vitro to in vivo. Nemirovskiy OV; Dufield DR; Sunyer T; Aggarwal P; Welsch DJ; Mathews WR Anal Biochem; 2007 Feb; 361(1):93-101. PubMed ID: 17187753 [TBL] [Abstract][Full Text] [Related]
14. The chemical biomarkers C2C, Coll2-1, and Coll2-1NO2 provide complementary information on type II collagen catabolism in healthy and osteoarthritic mice. Ameye LG; Deberg M; Oliveira M; Labasse A; Aeschlimann JM; Henrotin Y Arthritis Rheum; 2007 Oct; 56(10):3336-46. PubMed ID: 17907187 [TBL] [Abstract][Full Text] [Related]
15. Correlating changes in collagen secondary structure with aging and defective type II collagen by Raman spectroscopy. Dehring KA; Smukler AR; Roessler BJ; Morris MD Appl Spectrosc; 2006 Apr; 60(4):366-72. PubMed ID: 16613631 [TBL] [Abstract][Full Text] [Related]
16. Serum biomarkers for osteoarthritis. Wang MY Neurosurgery; 2010 Jun; 66(6):N21-2. PubMed ID: 20495416 [No Abstract] [Full Text] [Related]
18. Effects of etanercept on serum biochemical markers of cartilage metabolism in patients with spondyloarthropathy. Briot K; Roux C; Gossec L; Charni N; Kolta S; Dougados M; Garnero P J Rheumatol; 2008 Feb; 35(2):310-4. PubMed ID: 18203315 [TBL] [Abstract][Full Text] [Related]
19. Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders: a review of the literature. Bello AE; Oesser S Curr Med Res Opin; 2006 Nov; 22(11):2221-32. PubMed ID: 17076983 [TBL] [Abstract][Full Text] [Related]
20. Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development. Karsdal MA; Henriksen K; Leeming DJ; Mitchell P; Duffin K; Barascuk N; Klickstein L; Aggarwal P; Nemirovskiy O; Byrjalsen I; Qvist P; Bay-Jensen AC; Dam EB; Madsen SH; Christiansen C Biomarkers; 2009 May; 14(3):181-202. PubMed ID: 19399662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]